![Kaouthar Lbiati](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kaouthar Lbiati
Director/Board Member at
THERALASE TECHNOLOGIES INC.
Net worth: 41 906 $ as of 31/05/2026
Profile
Kaouthar Lbiati is currently an Independent Director at Theralase Technologies, Inc. since 2023 and Vice President-Strategy & Corporate Development at Cytovia Therapeutics, Inc. Former positions include Chief Executive, Financial Officer & Director at Hepion Pharmaceuticals, Inc. from 2025 to 2026, Executive Director-Strategic Planning at Immune Pharmaceuticals, Inc., and Head-Strategy & Portfolio at Steba Biotech SA. Education includes graduate degrees from London School of Economics & Political Science and ESSEC Business School, and a doctorate from Mohammed V University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/05/2026 | 246,507 ( 0.1% ) | 41 906 $ | 31/05/2026 | |
| 28/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Kaouthar Lbiati active positions
| Companies | Position | Start |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Director/Board Member | 06/06/2023 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Corporate Officer/Principal | - |
Former positions of Kaouthar Lbiati
| Companies | Position | End |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Chief Executive Officer | 16/03/2026 |
| IMMUNE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Steba Biotech SA
 Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Corporate Officer/Principal | - |
Training of Kaouthar Lbiati
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Theralase Technologies, Inc.
 Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mohammed V University
 Mohammed V University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Steba Biotech SA
Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Commercial Services |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
- Stock Market
- Insiders
- Kaouthar Lbiati
